Capital Fund Management S.A. Gilead Sciences, Inc. Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

A detailed history of Capital Fund Management S.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Capital Fund Management S.A. holds 473,516 shares of GILD stock, worth $46 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

473,516

Previous 46,117 926.77%

Holding current value

$46 Million

Previous $3.16 Million 1154.42%

% of portfolio

0.11%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$66.59 - $83.99 $28.5 Million - $35.9 Million	427,399 Added 926.77%	473,516 $39.7 Million
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $68.7 Million - $79.3 Million	-1,088,645 Reduced 95.94%	46,117 $3.16 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $49.1 Million - $59.9 Million	686,384 Added 153.08%	1,134,762 $83.1 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $28.1 Million - $31.9 Million	383,410 Added 590.15%	448,378 $36.3 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $4.8 Million - $5.24 Million	64,968 New	64,968 $4.87 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $8.87 Million - $10.1 Million	-114,717 Reduced 68.93%	51,707 $4.29 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $9.75 Million - $14 Million	-156,445 Reduced 48.45%	166,424 $14.3 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $2.27 Million - $2.59 Million	-38,145 Reduced 10.57%	322,869 $19.9 Billion
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $4.4 Million - $4.96 Million	-76,246 Reduced 17.44%	361,014 $22.3 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $2.66 Million - $3.33 Million	45,939 Added 11.74%	437,260 $26 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $9.19 Million - $10.4 Million	141,649 Added 56.73%	391,321 $28.4 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $1.63 Million - $1.76 Million	-24,111 Reduced 8.81%	249,672 $17.4 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $16 Million - $17.5 Million	251,860 Added 1148.84%	273,783 $18.9 Million
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $1.59 Million - $1.84 Million	21,923 New	21,923 $1.69 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $4.59 Million - $5.88 Million	-73,260 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $4.51 Million - $4.97 Million	73,260 New	73,260 $4.76 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $608,034 - $671,163	-9,727 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $13.7 Million - $15.4 Million	-221,421 Reduced 95.79%	9,727 $657,000
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $13.1 Million - $14.7 Million	209,911 Added 988.42%	231,148 $15 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $1.29 Million - $1.68 Million	21,237 New	21,237 $1.33 Million

Others Institutions Holding GILD

# of Institutions

1,963

Shares Held

995M

Call Options Held

10.5M

Put Options Held

9.86M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $122B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Gilead Sciences, Inc. Transaction History